Continuous infusion of recombinant porcine factor VIII for neurosurgical management of intracranial haemorrhage in a patient with severe haemophilia A with factor VIII inhibitor

被引：1
|
作者：
Ruan, Gordon J. [1 ]
Mao, Jimmy J. [1 ]
Sytsma, Terin T. [1 ]
Akogyeram, Ivy I. [2 ]
Wang, Yucai [3 ]
Ashrani, Aneel A. [3 ]
Pruthi, Rajiv K. [3 ]
机构：
[1] Mayo Clin, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Serv Pharm, Rochester, MN USA
[3] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
来源：
HAEMOPHILIA | 2020年 / 26卷 / 03期
关键词：
SEQUENCE; SAFETY; RFVIIA; OBI-1;
D O I：
10.1111/hae.13966
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E141 / E144
页数：4
相关论文
共 50 条
  • [31] Successful treatment of acute subdural haemorrhage with continuous intravenous infusion of factor VIII in a 17 year old with haemophilia A
    Richardson, NGB
    Miller, AL
    OShaughnessy, DF
    HAEMOPHILIA, 1996, 2 (03) : 173 - 176
  • [32] Acquired haemophilia and haemostatic control with recombinant porcine factor VIII: case series
    Campbell, Sally
    Mason, Jane
    Prasad, Ritam
    Ambrose, Harriet
    Hunt, Stewart
    Tran, Huyen
    INTERNAL MEDICINE JOURNAL, 2021, 51 (02) : 215 - 219
  • [33] Unexpected pharmacokinetics of recombinant porcine factor VIII in a patient with acquired factor VIII deficiency and spontaneous epidural haematoma
    Shatzel, J. J.
    Azar, S.
    Scherber, R.
    Gay, N.
    Deloughery, T. G.
    VanSandt, A.
    Kruse-Jarres, R.
    Recht, M.
    Taylor, J. A.
    HAEMOPHILIA, 2017, 23 (05) : e453 - e456
  • [34] Acquired haemophilia (acquired factor VIII inhibitor)
    Ceresetto, Jose M.
    Duboscq, Cristina
    Fondevila, Carlos
    Tezanos Pinto, Miguel
    MEDICINA-BUENOS AIRES, 2015, 75 (04) : 231 - 238
  • [35] Frequency of Factor VIII (FVIII) Inhibitor in Haemophilia A
    Borhany, Munira
    Kumari, Meena
    Shamsi, Tahir
    Naz, Arshi
    Farzana, Tasneem
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2012, 22 (05): : 289 - 293
  • [36] The influence of prophylactic factor VIII in severe haemophilia A
    Gissel, M.
    Whelihan, M. F.
    Ferris, L. A.
    Mann, K. G.
    Rivard, G. E.
    Brummel-Ziedins, K. E.
    HAEMOPHILIA, 2012, 18 (02) : 193 - 199
  • [37] PERIOPERATIVE MANAGEMENT OF PATIENTS WITH SEVERE HAEMOPHILIA A WITH RECOMBINANT FACTOR VIII FC FUSION PROTEIN (RFVIIIFC)
    Bocchinfuso, S.
    O'Donovan, M.
    Singleton, E.
    Benson, J.
    Byrne, M.
    Ryan, K.
    O'Donnell, J. S.
    O'Connell, N. M.
    HAEMOPHILIA, 2021, 27 : 105 - 106
  • [38] Continuous infusion of extended half-life factor VIII (efmoroctocog alpha) for surgery in severe haemophilia A
    Hovinga, I. C. L. Kremer
    Schutgens, R. E. G.
    van der Valk, P. R.
    van Vulpen, L. F. D.
    Mauser-Bunschoten, E. P.
    Fischer, K.
    HAEMOPHILIA, 2018, 24 (04) : E280 - E283
  • [39] CONTINUOUS-INFUSION OF PORCINE FACTOR-VIII IN PATIENTS WITH SEVERE HEMOPHILIA-A AND INHIBITORS
    MCKERNAN, AM
    HAY, CRM
    BOLTONMAGGS, PBM
    CASTAMAN, G
    GOLDSMITH, JC
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1025 - 1025
  • [40] CONTINUOUS-INFUSION OF FACTOR-VIII CONCENTRATE TO A PATIENT WITH SEVERE VONWILLEBRAND DISEASE
    MONTORO, JB
    ALTISENT, C
    PINEDA, A
    RODRIGUEZ, S
    TUSELL, JM
    TRANSFUSION, 1993, 33 (05) : 443 - 443
12345